GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
4
Ucap Cloud Information Technology Co.,Ltd
688228
5
Yangtze Optical Electronic
688143
CN Stock MarketDetailed Quotes
002793 Luoxin Pharmaceuticals Group Stock
- 3.64
- -0.05-1.36%
Market Closed Jan 24 15:00 CST
3.96BMarket Cap-5.68P/E (TTM)
3.70High3.61Low114.90KlotVolume3.69Open3.69Pre Close41.81MTurnover1.06%Turnover RatioLossP/E (Static)1.09BShares5.8052wk High1.88P/B3.95BFloat Cap3.2252wk Low4.06Limit Up1.09BShs Float27.94Historical High3.32Limit Down2.44%Amplitude3.22Historical Low--Dividend TTM3.64Avg Price73.31KlotAsk--Div YieldTTM100Lot Size39.91KlotBid
Luoxin Pharmaceuticals Group Stock News
Luoxin Pharmaceutical: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
Luoxin Pharmaceutical: Announcement on the progress of capital increases and related transactions to holding subsidiaries
Luoxin Pharmaceutical: Announcement on changes in accounting estimates
Luoxin Pharmaceutical: Announcement on capital increase and related transactions to holding subsidiaries
Luoxin Pharmaceutical: Announcement on the completion of a non-transactional transfer of the 2024 Employee Stock Ownership Plan
Luoxin Pharmaceutical: Announcement of the resolution of the first shareholders\' meeting on the 2024 Employee Stock Ownership Plan
Luoxin Pharmaceutical: Luoxin Pharmaceutical Group Co., Ltd. 2024 Employee Stock Ownership Plan
Luoxin Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Luoxin Pharmaceutical: Legal Opinion of the Shanghai Branch of Beijing King & Wood Mallesons on the 2024 Second Extraordinary General Meeting of Shareholders of Luoxin Pharmaceutical Group Co., Ltd.
Luoxin Pharmaceutical: 2024 Employee Stock Ownership Plan (Draft) Summary
Luoxin Pharmaceutical: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Luoxin Pharmaceutical: Board of Directors Compliance Statement on the Company\'s 2024 Employee Stock Ownership Plan (Draft)
Luoxin Pharmaceutical: 2024 Employee Stock Ownership Plan (Draft)
Luoxin Pharmaceutical: 2024 Semi-Annual Financial Report
Luoxin Pharmaceutical: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Luoxin Pharmaceuticals Group Stock: Announcement Regarding Replacement of Independent Financial Advisor and Sponsor for Major Asset Restructuring.
Luoxin Pharmaceuticals Group Stock: Legal opinion of Beijing Jindu Law Firm Shanghai Branch on the first interim shareholders' meeting of Luoxin Pharmaceuticals Group Stock Co., Ltd. in 2024.
Luoxin Pharmaceuticals Group Stock: Notice Regarding the Election of Employee Representative Supervisors
Luoxin Pharmaceuticals Group Stock: Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.
Luoxin Pharmaceuticals Group Stock: Announcement on Holding Subsidiary Passing the On-Site Inspection of USA FDA